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Asthma affects 300 million people world-wide and 
more than 100 million persons will be diagnosed by 
2025.
[1]
 Tamaka Shvasa is Vata-Kapha  Pradhana  and 
Pita Sthana Samudbhava Vyadhi.
[2]
 When Vata is 
obstructed by Malaroopa Kapha in Pranavaha Srotas, 
its movement becomes Pratiloma and  Atitivra 
Vega.
[3]
 In Tamaka Shvasa, Nija Hetus (Intrinsic 
factors) like unwholesome diet and  Agantus Hetus  
like Raja, Dhuma, Shita Vata etc. are involved.
[4] 
Due 
to Jatharagnimandya and Rasagnimandya, 
Malaroopa Kapha is produced more in Tamaka 
Shvasa. In these conditions drugs having  properties 
of Vatanulomana, Vata-Kapha Hara, Ushna plays an 
important  role  in  Chikitsa  of  Tamaka  Shvasa.
[5]
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this purpose, Shirishadi tablet was selected. Both 
contents of  tablet have Vata-Kaphahara, Deepana, 
Rasayana and Shvasaghna properties. 
OBJECTIVES 
To assess the efficacy of Shirishadi tablet in 
management of Tamaka Shvasa and to provide safe 
and effective remedy to the patients of Tamaka 
Shvasa. 
MATERIALS AND METHODS 
Selection of the patients  
In present study, 15 patients having classical signs and 
symptoms of Tamaka Shvasa were selected from 
O.P.D. & I.P.D. of Kayachikitsa, Government 
Akhandanand Ayurveda Hospital and Maniben 
Ayurved Hospital, Ahmedabad.   
Criteria for Diagnosis  
The patients were diagnosed on the basis of classical 
signs and symptoms of Tamaka Shvasa described in 
Ayurvedic classics. The details of each patient were 
noted in specific proforma. 
Inclusion Criteria 
1. Patients of Tamaka Shwasa in the age group of 16 
- 60 were taken. 
A B S T R A C T  
Tamaka Shvasa is described as a most difficult to cure (Yapya) among all diseases in Ayurveda. In 
present study Tamaka Shvasa is correlated with Bronchial Asthma because of its symptomatology is 
much similar with Tamaka Shvasa. In modern medical science, steroids and bronchodilators  are 
mainly used for its management, but they cause certain side effects. Present study was undertaken to 
provide safe and effective remedy for Tamaka Shvasa through Ayurvedic medicaments. Shirishadi 
tablet was given as internal medicine for 30 days. Upto 60% relief was found in signs and symptoms 
of Tamaka Shvasa.  
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2. The patients having clinical features of Tamaka 
Shvasa as per Ayurvedic classics and modern 
medical science were selected. 
3. Patients who are weak and especially not able to 
tolerate Sansodhana therapy were considered. 
4. Chronicity varies from 1 to 8 years. 
Exclusion Criteria 
1. Patients having complications like CCF, Cor-
pulmonale, Emphysema, Pneumonia, Tuberculosis 
& malignancy etc were not considered in research 
work. 
Investigations 
1. Routine hematological investigation such as Hb%, 
TLC, DLC, ESR.  
2. Microscopic and routine examination of Urine and 
stool (if needed). 
3. Peak Expiratory Flow Rate by Mini Peak Flow 
meter. 
4. X-ray chest and sputum examinations whenever 
required. These investigations were conducted to 
exclude any other underlying pathology. 
Grouping and management 
Shirishadi tablet 
 Dose :  4 tablet (each contain 500mg) twice a day. 
 Duration : 4 weeks 
 Anupana : Ushnodaka (Luke warm water) 
 Criteria for Assessment : The following scoring 
pattern had  prepared for the assessment of the 
therapy on the basis of signs and symptoms of the 
disease.  
A. Cardinal Symptoms  
The Medical Research Council (M.R.C.) dyspnoea scale 
for grading the degree of breathlessness was adopted 
for Shvasakastata. 
Shvasakastata (Breathlessness) 
 0 - Not trouble by breathlessness except on 
strenuous exercise  
 1 - Troubled by shortness of breath on climbing 2-
3 storeys. 
 2 - Walks slower than person of same age or stops 
after 15 min walking. 
 3 - Stops after walking 100 yards or after a few 
minute on ground level. 
 4 - Breathlessness at rest. 
Ativege Kasate (Frequent bouts of coughing) 
 0 - No Kasa 
 1 - Kasa Vega sometimes not troublesome. 
 2 - Kasa Vega with pain, not disturbing the sleep. 
 3 - Very troublesome, Kasa does not even allow to 
sleep at night. 
Parsve Avagrihyate (Chest tightness) 
 0 - No such feeling of chest tightness. 
 1 - Mild chest tightness during attack. 
 2 - Moderate chest tightness during attack. 
 3 - Severe chest tightness during attack. 
Ghurghurakam (Wheezing) 
 0 - No wheezing. 
 1 - Wheezing only during attack. 
 2 - Very often wheezing sound. 
 3 - Wheezing throughout the day. 
B. Associated Symptoms  
Peenasa (Coryza) 
 0 - No Peenasa. 
 1 - Peenasa along with the attack. 
 2 - Very often Peenasa even without attack. 
 3 - Always Peenasa persisting. 
Anindra (Disturbed sleep due to breathlessness) 
 0 - Sound Sleep. 
 1 - Undisturbed late sleep. 
 2 - Sleep disturbed in late night and early 
morning. 
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 3 - No sleep. 
Shayane Shvasa Pidita (Breathlessness during lying 
posture) 
 0 - No Shvasa Pidita during Sleep. 
 1 - Occasional Shvasa Pidita during Sleep. 
 2 - Very often Shvasa Pidita during Sleep. 
 3 - Always Shvasa Pidita during Sleep. 
Asinolabhate Saukhyam (Comfort in sitting posture) 
 0 - can sleep easily. 
 1 - 1 pillow required. 
 2 - 2 pillow required. 
 3 - 3 pillow required. 
 4 - cant sleep, spontaneous sitting upright. 
Lalate Sweda (Sweating over forehead) 
 0 - No Sweating over forehead. 
 1 - Mild perspiration. 
 2 - Moderate perspiration. 
 3 - Excessive perspiration. 
Vishushkasyata (Dryness of mouth) 
 0 - No Vishushkasyata. 
 1 - Occasional Vishushkasyata. 
 2 - Very often Vishushkasyata 
 3 - Always Vishushkasyata. 
Assessment on the basis of complaints 
Controlled - 100% relief in complaints 
Marked Relief - ≥ 75% relief in complaints 
Moderate Relief - ≥ 50 - 74 % relief in complaints 
Mild Relief - ≥ 25 - 49 % relief in complaints 
No Relief - < 25% relief in complaints 
 
STATISTICAL ANALYSIS 
The paired ‘t’ test had used for analyzing the data 
generated during the study. The value of P<0.05 or 
0.01 is considered as statistically significant, the value 
of P<0.001 is considered statistically highly significant, 
the value of P>0.05 is considered statistically 
insignificant.  
RESULT 
Improvement in cardinal symptoms were 
Shwasakastata 60%, Ativege Kasate 58.06%, Parsve 
Avagrihyate 60.97% and Ghurghurakam 50% which 
were highly significant. 
The total effect on signs and symptoms is as shown 
below in Table 1, effect on Hematological values and 
P.E.F.R. in Table 2. The Table 3 depicts the overall 
effect of therapy. 
Table 1: Total effect of therapy on signs and 

















Table 2: Effect on the Haematocrit Values of 15 
Patients of Tamaka Shvasa. 
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Table 3: Overall Effect on 15 Patient of Tamaka 
Shvasa 
Assessment Group A 
No. of Pts % 
Marked responses (>75%) 0 0 
Moderate response (50-75%) 13 86.66 
Mild improvement (25-50%) 2 13.33 
No response (<25%) 0 0 
Overall effects show that complete remission was not 
found while 86.66% of cases found moderate relief 
and 13.33%  cases found mild relief in this group.  
DISCUSSION 
Statistically highly significant effect was observed on 
Shwasakastata, Ativege Kasate, Parsve Avagrihyate, 
Ghurghurakam, Anindra, Shayane Shwasa Pidita, 
Asino Labhate Saukhyam, Lalate Sweda and 
Vishushkasyata while significant effect was noted on 
Peenasa. 
The increase in the Peak Expiratory Flow Rate values 
after treatment suggest the improvement in airway 
obstruction in alveoli of lungs and increase in 
ventilatory functions. 
Probable mode of action 
In Tamaka Shwasa Vata-Kapha are main Dosha while 
it originates in Pittasthana,
[6]
 so Pitta also involves 
indirectly. Shirisha is Tridoshaghna while Pippali is 
Vata-Kapha Hara, Pitaavirodhi
[7]
and Rasayana Dravya 
of Pranavaha Srotasa. Pippali is pivotal for the 
purification process in the body, because it cleans the 
Srotas that transports nutrients and help in the 
removal of wastes from the body. The main factor in 
the disease is Malaroopa Kapha along with Vata and 
the properties of Deepana and Pachana of drug help 
to decrease production of Malaroopa Kapha from 
Rasa Dhatu and consequently obstruction of Vata will 
clear. Extract from Shirisha include polyphenols, 
flavonoids, terpenes, amines etc. all of which are 
observed to have potential anti-allergic activity
[8]
 
while Piperine, major compound of Pippali has strong 





Shirisha is best Vishaghna (anti poisonous) Dravya.
[10] 
It contains anti allergic and anti asthmatic activity. 
Pippali is good Rasayana Dravya of Pranavaha Srotas 
(respiratory system). In Tamaka Shwasa immunity is 
decreased and Pippali is good immunomodulatory 
drug. Overall both Pippali and Shirish showed good 
anti asthmatic activity and found beneficial in cases of 
allergic bronchial asthma. Shirishadi tablet can be 
taken for long time and have no any side effects if it is 
taken in proper dose. 
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